Showing results (1-10 of 38) with videos related to

Sort By:
Pageof 4
Pharmacogenomics|June 27, 2015
Pharmacogenetics in electroconvulsive therapy and adjunctive medicationsHooman Mirzakhani, Martijn S van Noorden, Jesse Swen, et al.
International Journal of Adolescent Medicine and Health|November 12, 2015
Burnout, depression and anxiety in preclinical medical students: a cross-sectional surveyLennard T van Venrooij, Pieter C Barnhoorn, Erik J Giltay, et al.
Drug and Alcohol Dependence|May 23, 2017
Treatment consumption and treatment re-enrollment in GHB-dependent patients in The NetherlandsMartijn S van Noorden, Ton Mol, Jeroen Wisselink, et al.
Drug and Alcohol Dependence|January 22, 2013
Sociodemographic and substance use characteristics of γ hydroxybutyrate (GHB) dependent inpatients and associations with dependence severityTibor M Brunt, Maarten W Koeter, Nina Hertoghs, et al.
Pharmacogenetics and Genomics|August 1, 2015
Aberrant CYP2D6 metabolizer phenotypes do not show increased frequency in patients undergoing ECT after antidepressant therapyHooman Mirzakhani, Juliët van Dormolen, Karen van der Weide, et al.
General Hospital Psychiatry|June 27, 2009
Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-knownMartijn S van Noorden, Lieselotte C A M van Dongen, Frans G Zitman, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|April 25, 2009
Effects of childhood trauma on HPA-axis reactivity in women free of lifetime psychopathologyEllen R Klaassens, Martijn S van Noorden, Erik J Giltay, et al.
Nederlands Tijdschrift Voor Geneeskunde|November 3, 2010
[Gamma-hydroxybutyric acid (GHB) dependence and the GHB withdrawal syndrome: diagnosis and treatment]Martijn S van Noorden, Rama Kamal, Cor A J de Jong, et al.
Pageof 4